Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
Dec. 31, 2012
Dec. 31, 2011
ASSETS    
Cash and cash equivalents $ 123,000 $ 92,000
Inventories 59,000 12,000
Prepaid expenses 20,000 0
Total Current Assets 202,000 104,000
Patents, net 24,000 25,000
Total Other Assets 24,000 25,000
TOTAL ASSETS 226,000 129,000
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Accounts payable 878,000 806,000
Accrued interest 1,253,000 1,598,000
Accrued expenses 1,173,000 607,000
Line of credit 27,000 25,000
Warrant liability 1,378,000 158,000
Settlement note payable 702,000 0
Demand notes payable 63,000 266,000
Convertible debentures, net of discount of $809,000 and $54,000, current portion 463,000 775,000
Convertible debentures 625,000 995,000
Total Current Liabilities 6,562,000 5,230,000
Stockholders' Deficit:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized:      
Series C - 96,230 and 96,230 shares issued and outstanding at December 31, 2012 and December 31, 2011, respectively 1,000 1,000
Series H - 25,000 and 25,000 shares issued and outstanding at December 31, 2012 and December 31, 2011, respectively 0 0
Series I - 1,666,667 shares issued and outstanding at December 31, 2012 and December 31, 2011, respectively 2,000 2,000
Common stock - $0.001 par value; 600,000,000 shares authorized; and 500,573,746 and 269,299,838 shares issued and outstanding at December 31, 2012 and December 31, 2011, respectively 501,000 269,000
Additional paid-in capital 82,216,000 78,422,000
Accumulated deficit (88,966,000) (83,795,000)
Noncontrolling interest (90,000) 0
Total Stockholders' Deficit (6,336,000) (5,101,000)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 226,000 $ 129,000